Report Content
Chapter 1 Methodology & Scope
1.1 Industry coverage
1.2 Market scope and definitions
1.3 Base estimates & working
1.3.1 Data collection
1.4 Forecast parameters
1.5 COVID-19 impact analysis at global level
1.6 Data validation
1.7 Data sources
1.7.1 Primary
1.7.2 Secondary
1.7.2.1 Paid sources
1.7.2.2 Public sources
Chapter 2 Executive Summary
2.1 3D cell culture industry 3600 synopsis, 2018 - 2032
2.1.1 Business trends
2.1.2 Type trends
2.1.3 Application trends
2.1.4 End-use trends
2.1.5 Regional trends
Chapter 3 3D Cell Culture Industry Insights
3.1 Industry segmentation
3.2 Industry landscape, 2018 – 2032
3.3 Industry impact forces
3.3.1 Growth drivers
3.3.1.1 Growing demand for better in vitro models
3.3.1.2. Advancement in 3 D cell culture techniques
3.3.1.3 Increasing focus on developing alternatives to animal testing
3.3.2 Industry pitfalls & challenges
3.3.2.1. Lack of consistency in 3 D cell culture products
3.3.2.2 High cost of cell biology research
3.4 Growth potential analysis
3.4.1 By type
3.4.2 By application
3.4.3 By end-use
3.5 COVID-19 impact analysis
3.6 Regulatory landscape
3.7 Advancement in 3D cell culture
3.8 Pricing analysis, by type, 2022
3.9 Porter’s analysis
3.10 PESTEL analysis
Chapter 4 Competitive Landscape, 2022
4.1 Introduction
4.2 Company market share analysis
4.3 Company matrix analysis, 2022
4.4 Strategy dashboard, 2022
4.5 Competitive analysis of major market players
4.6 Competitive positioning matrix
4.7 Strategic outlook matrix
Chapter 5 3D Cell Culture Market, By Type
5.1 Key type trends
5.2 Scaffold-based 3D cell cultures
5.2.1 Market estimates and forecast, 2018 - 2032 (USD Million)
5.2.2 Hydrogels / ECM analogs
5.2.2.1 Market estimates and forecast, 2018 - 2032 (USD Million)
5.2.3 Polymeric scaffolds
5.2.3.1 Market estimates and forecast, 2018 - 2032 (USD Million)
5.2.4 Micro-patterned surface microplates
5.2.4.1 Market estimates and forecast, 2018 - 2032 (USD Million)
5.2.5 Nanofiber-based scaffolds
5.2.5.1 Market estimates and forecast, 2018 - 2032 (USD Million)
5.3 Scaffold-free 3D cell cultures
5.3.1 Market estimates and forecast, 2018 - 2032 (USD Million)
5.3.2 Hanging drop microplates
5.3.2.1 Market estimates and forecast, 2018 - 2032 (USD Million)
5.3.3 Spheroid microplates with ULA coating
5.3.3.1 Market estimates and forecast, 2018 - 2032 (USD Million)
5.3.4 Magnetic levitation & 3D bioprinting
5.3.4.1 Market estimates and forecast, 2018 - 2032 (USD Million)
5.3.5 3D petri dishes
5.3.5.1 Market estimates and forecast, 2018 - 2032 (USD Million)
5.4 Bioreactors
5.4.1 Market estimates and forecast, 2018 - 2032 (USD Million)
5.5 Microfluidic 3D cell culture
5.5.1 Market estimates and forecast, 2018 - 2032 (USD Million)
Chapter 6 3D Cell Culture Market, By Application
6.1 Key application trends
6.2 Cancer
6.2.1 Market estimates and forecast, 2018 - 2032 (USD Million)
6.3 Stem cell research
6.3.1 Market estimates and forecast, 2018 - 2032 (USD Million)
6.4 Drug discovery & toxicology testing
6.4.1 Market estimates and forecast, 2018 - 2032 (USD Million)
6.5 Tissue engineering & regenerative medicine
6.5.1 Market estimates and forecast, 2018 - 2032 (USD Million)
6.6 Other applications
6.6.1 Market estimates and forecast, 2018 - 2032 (USD Million)
Chapter 7 3D Cell Culture Market, By End-use
7.1 Key end-use trends
7.2 Biotechnology and pharmaceutical industries
7.2.1 Market estimates and forecast, 2018 - 2032 (USD Million)
7.3 Research laboratories and institutes
7.3.1 Market estimates and forecast, 2018 - 2032 (USD Million)
7.4 Hospitals and diagnostic centers
7.4.1 Market estimates and forecast, 2018 - 2032 (USD Million)
7.5 Other end uses
7.5.1 Market estimates and forecast, 2018 - 2032 (USD Million)
Chapter 8 3D Cell Culture Market, By Region
8.1 Key regional trends
8.2 North America
8.2.1 U.S.
8.2.2 Canada
8.3 Europe
8.3.1 Germany
8.3.2 UK
8.3.3 France
8.3.4 Italy
8.3.5 Spain
8.3.6 Poland
8.3.7 Switzerland
8.3.8 Netherlands
8.3.9 Rest of Europe
8.4 Asia Pacific
8.4.1 China
8.4.2 Japan
8.4.3 India
8.4.4 Australia
8.4.5 South Korea
8.4.6 Indonesia
8.4.7 Thailand
8.4.8 Singapore
8.4.9 Malaysia
8.4.10 Rest of Asia Pacific
8.5 Latin America
8.5.1 Brazil
8.5.2 Mexico
8.5.3 Argentina
8.5.4 Colombia
8.5.5 Peru
8.5.6 Rest of Latin America
8.6 Middle East & Africa
8.6.1 South Africa
8.6.2 Saudi Arabia
8.6.3 UAE
8.6.4 Iraq
8.6.5 Israel
8.6.6 Rest of Middle East & Africa
Chapter 9 Company Profiles
9.1 BiomimX SRL
9.2 CN Bio Innovations Ltd.
9.3 Corning Incorporated
9.4 Hurel Corporation
9.5 InSphero AG
9.6 Lonza AG
9.7 Merck KGaA
9.8 MIMETAS BV
9.9 Nortis Inc.
9.10 Thermo Fisher Scientific
9.11 Sartorius AG
9.12 Promocell GmbH
9.13 Becton, Dickinson and Company
